Gaucher’s Disease 2018-2028 – Forecast In 30 Major Markets –

The “Epiomic
Epidemiology Series: Gaucher’s Disease Forecast In 30 Major Markets
2018-2028” report has been added to’s

This report provides the current prevalent population for GD across 30
Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland,
Netherlands, Belgium, Norway, Sweden, Finland, Denmark, Austria, Greece,
Romania, Slovenia, Czech Republic, Lithuania, Estonia, Russia, Turkey,
Japan, China, South Korea, India, Brazil, Mexico, Argentina) split by
gender and 5-year age cohort.

Along with the current prevalence, the report provides an overview of
the genotypes and the prevalence of associated disorders of GD. The
report also contains a disease overview of the risk factors, disease
diagnosis and prognosis along with specific variations by geography and

Providing a value-added level of insight from our analysis team, several
of the main co-morbidities of GD have been quantified and presented
alongside the overall prevalence figures. These sub-populations within
the main disease are also included at a country level across the 10-year
forecast snapshot.

Main symptoms and co-morbidities for GD include:

Reasons to buy

Key Topics Covered:

For more information about this report visit

View source version on

Leave a Comment